Glucagon-like peptide-1-based incretin agonists in obesity-related heart failure with preserved ejection fraction: A systematic review and meta-analysis

doi:10.13105/wjma.v14.i2.119849

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

(26)

(19)

(0)

(302)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Meta-Anal. Jun 18, 2026; 14(2): 119849
Published online Jun 18, 2026. doi: 10.13105/wjma.v14.i2.119849

Full Size Figure Download Figure

Figure 1 PRISMA 2020 flow diagram illustrating the study identification, screening, eligibility assessment, and inclusion process. A total of 377 records were identified across four databases and additional sources. Following duplicate removal and title/abstract screening, 15 full-text reports were assessed for eligibility, of which 8 publications [comprising 3 primary randomized controlled trials (RCT) and 5 secondary or pooled analyses] were included in the systematic review. Three RCTs (n = 1876) were included in quantitative synthesis. HFpEF: Heart failure with preserved ejection fraction.

Citation: Al Mashtoub E, Hteit A, Bedran A, Al Banna J, El Hachem C, Obeid N, Msheik M, Tlais M, Abdulaal R. Glucagon-like peptide-1-based incretin agonists in obesity-related heart failure with preserved ejection fraction: A systematic review and meta-analysis. World J Meta-Anal 2026; 14(2): 119849
URL: https://www.wjgnet.com/2308-3840/full/v14/i2/119849.htm
DOI: https://dx.doi.org/10.13105/wjma.v14.i2.119849

Al Mashtoub E, Hteit A, Bedran A, Al Banna J, El Hachem C, Obeid N, Msheik M, Tlais M, Abdulaal R. Glucagon-like peptide-1-based incretin agonists in obesity-related heart failure with preserved ejection fraction: A systematic review and meta-analysis. World J Meta-Anal 2026; 14(2): 119849 [DOI: 10.13105/wjma.v14.i2.119849]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.